Primary Myelofibrosis Completed Phase 2 Trials for Lenalidomide (DB00480)

Also known as: Myelofibrosis, Primary / Osteomyelofibrosis / Chronic idiopathic myelofibrosis

IndicationStatusPhase
DBCOND0001581 (Primary Myelofibrosis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00227591Lenalidomide and Prednisone in Treating Patients With MyelofibrosisTreatment